International Ophthalmology

, Volume 38, Issue 5, pp 2159–2162 | Cite as

Turning a blind eye: HTLV-1-associated uveitis in Indigenous adults from Central Australia

  • Rusheng Chew
  • Timothy Henderson
  • Jaskirat Aujla
  • Eline Whist
  • Lloyd EinsiedelEmail author
Case Report



We describe the first two cases of HTLV-1 associated uveitis to be associated with HTLV-1c subtype infection.


Case report.


Uveitis was demonstrated in two Indigenous Australian men, both of whom had high HTLV-1c proviral loads in peripheral blood. Visual outcomes were poor in each case.


Clinicians should be aware of HTLV-1c infection as a cause of uveitis in Australia, and HTLV-1 serology should be included in the basic uveitis work-up in HTLV-1-endemic areas.


HTLV-1 Uveitis Central Australia Indigenous 



RC wrote the manuscript. LE, TH, JA and EW revised the manuscript critically. All authors have approved the final submitted version of the manuscript.

Compliance with ethical standards

Conflicts of interest

All authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any research studies with human participants or animals performed by any of the authors.


  1. 1.
    Northern Territory Department of Health and Families (2010) Central Australia regional plan 2010–2012. Northern Territory Government, DarwinGoogle Scholar
  2. 2.
    Einsiedel L, Fernandes L, Joseph S (2013) Non-communicable diseases, infection and survival in a retrospective cohort of Indigenous and non-indigenous adults in Central Australia. BMJ Open 3:e003070CrossRefPubMedCentralGoogle Scholar
  3. 3.
    Australian Institute of Health and Welfare/Australian Bureau of Statistics. The health and welfare of Australia’s Aboriginal and Torres Strait Islander peoples. 2008 Commonwealth of Australia, Australian Bureau of Statistics catalogue number 4704.0, CanberraGoogle Scholar
  4. 4.
    Einsiedel L, Spelman T, Goeman E et al (2014) Clinical associations of Human T-lymphotropic virus type 1 in an Indigenous Australian population. PLOS Negl Trop Dis 8:e2643CrossRefPubMedCentralGoogle Scholar
  5. 5.
    Martin F, Taylor GT, Jacobson S (2014) Inflammatory manifestations of HTLV-1 and their therapeutic options. Expert Rev Clin Immunol 10:1531–1546CrossRefPubMedCentralGoogle Scholar
  6. 6.
    Merle H, Smadja D, Le Hoang P et al (1996) Ocular manifestations in patients with HTLV-1 associated infection—a clinical study of 93 cases. Jpn J Ophthalmol 40:260–270PubMedPubMedCentralGoogle Scholar
  7. 7.
    Yamaguchi K (1994) Human T-lymphotropic virus type I in Japan. Lancet 343:213–216CrossRefGoogle Scholar
  8. 8.
    Murphy EL, Figueroa JP, Gibbs WN et al (1991) Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica: I demographic determinants. Am J Epidemiol 133:1114–1124CrossRefPubMedCentralGoogle Scholar
  9. 9.
    Gessain A, Cassar O (2012) Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol 3:388CrossRefPubMedCentralGoogle Scholar
  10. 10.
    Einsiedel L, Woodman RJ, Flynn M et al (2016) Human T-lymphotropic virus type 1 infection in an Indigenous Australian population: epidemiological insights from a hospital-based cohort study. BMC Public Health 16:787CrossRefPubMedCentralGoogle Scholar
  11. 11.
    Einsiedel LJ, Pham H, Woodman RJ et al (2016) The prevalence and clinical associations of HTLV-1 infection in a remote Indigenous community. Med J Aust 205:305–309CrossRefPubMedCentralGoogle Scholar
  12. 12.
    Nagai M, Usuku K, Matsumoto W et al (1998) Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 4:586–593CrossRefPubMedCentralGoogle Scholar
  13. 13.
    Einsiedel L, Fernandes L, Spelman T et al (2012) Bronchiectasis is associated with human T-lymphotropic virus 1 infection in an Indigenous Australian population. Clin Infect Dis 54:43–50CrossRefPubMedCentralGoogle Scholar
  14. 14.
    Einsiedel L, Cassar O, Goeman E et al (2014) Higher human T-lymphotropic virus type 1 subtype C proviral loads are associated with bronchiectasis in Indigenous Australians: results of a case-control study. Open Forum Infect Dis 1:ofu023CrossRefPubMedCentralGoogle Scholar
  15. 15.
    Mochizuki M, Watanabe T, Yamaguchi K et al (1992) HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res 83:236–239CrossRefPubMedCentralGoogle Scholar
  16. 16.
    Miyanaga M, Shimizu K, Kawaguchi T et al (2009) A clinical survey of uveitis in HTLV-I endemic region. OculImmunolInflamm 17:335Google Scholar
  17. 17.
    Merle H, Cabre P, Olindo S et al (2002) Ocular lesions in 200 patients infected by the human T-cell lymphotropic virus type 1 in Martinique (French West Indies). Am J Ophthalmol 134:190–195CrossRefPubMedCentralGoogle Scholar
  18. 18.
    Pinheiro SR, Carneiro-Proietri AB, Lima-Martins MV et al (1996) HTLV-I/II seroprevalence in 55 Brazilian patients with idiopathic uveitis. Rev Soc Bras Med Trop 29:383–384CrossRefPubMedCentralGoogle Scholar
  19. 19.
    Kamoi K, Mochizuki M (2012) HTLV-1 uveitis. Front Microbiol 3:270CrossRefPubMedCentralGoogle Scholar
  20. 20.
    Yoshimura K, Mochizuki M, Araki S et al (1993) Clinical and immunologic features of human T-cell lymphotropic virus type I uveitis. Am J Ophthalmol 116:156–163CrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2017

Authors and Affiliations

  • Rusheng Chew
    • 1
    • 2
    • 3
  • Timothy Henderson
    • 4
  • Jaskirat Aujla
    • 4
  • Eline Whist
    • 4
  • Lloyd Einsiedel
    • 1
    • 5
    Email author
  1. 1.Department of Infectious DiseasesAlice Springs HospitalAlice SpringsAustralia
  2. 2.Barwon HealthGeelongAustralia
  3. 3.Mayne Medical SchoolUniversity of QueenslandBrisbaneAustralia
  4. 4.Department of OphthalmologyAlice Springs HospitalAlice SpringsAustralia
  5. 5.Baker IDI Heart and Diabetes Institute Central AustraliaAlice SpringsAustralia

Personalised recommendations